With Bharat Biotech planning to ramp up its capacities for vaccine productions, Borosil could be a major beneficiary.
The stock has just completed a breakout retest and we could look for a bounce from here. (buy only if it bounces, else we'll look for a bounce around 206)
Long after bounce around current price.
SL below 205.
I would double my allocation above the marked price of 245 for much higher targets.
The stock has just completed a breakout retest and we could look for a bounce from here. (buy only if it bounces, else we'll look for a bounce around 206)
Long after bounce around current price.
SL below 205.
I would double my allocation above the marked price of 245 for much higher targets.